辛波莫德|T6403

Siponimod
1230487-00-9

￥259 1mg 起订

￥366 2mg 起订

￥547 5mg 起订

上海更新日期：2024-09-14

TargetMol中国（陶术生物）

VIP12年

联系人：邵小姐

电话：021-021-33632979拨打

手机：15002134094 拨打

邮箱：marketing@targetmol.com

产品详情:

中文名称：: 辛波莫德

英文名称：: Siponimod

CAS号：: 1230487-00-9

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: 99.29%

产品类别：: 抑制剂

货号：: T6403

Product Introduction

Bioactivity

名称	Siponimod
描述	BAF312 (Siponimod (BAF-312)), a next-generation S1P receptor modulator, is specific for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, respectively. The specificity of BAF312 for S1P1 and S1P5 receptors exhibits >1000-fold over S1P2, S1P3 and S1P4 receptors.
细胞实验	Agonist-mediated internalization of S1P1 receptors in CHO cells analysed by flow cytometry Myc-tag hS1P1 cells are incubated for 1 h with agonist at 37°C in standard culture medium followed by a PBS wash. An aliquot is kept on ice for 3 h, while another aliquot is left for 3 (or 12) h in culture medium (no agonist) at 37°C. The cells are then incubated either with 4 μg/mL monoclonal mouse anti C-myc IgG1 antibody or with isotype control mouse IgG1 for 60 min at 4°C, followed by an incubation with 1 μg/mL of Alexa488-labelled goat anti-mouse secondary conjugates. The cells are subjected to flow cytometry measurements using 10000 viable cells per sample.(Only for Reference)
激酶实验	GTPγ[35S] binding assay: The cells are homogenized and centrifuged at 26900 × g for 30 min at 4°C. Membranes are re-suspended in 20 mM HEPES (pH 7.4), 100 mM NaCl, 10 mM MgCl2, 1 mM EDTA and 0.1% fat-free BSA at 2–3 mg protein/mL. GTPγ[35S] binding assay is performed with the membranes (75 mg protein /mL in 50 mM HEPES, 100 mM NaCl, 10 mM MgCl2, 20 μg/mL saponin and 0.1% fat-free BSA (pH 7.4), 5 mg/mL with wheat-germ agglutinin-coated scintillation proximity assay-bead, and 10 μM GDP for 10–15 min. The GTPγ[35S]-binding reaction is started by the addition of 200 pM GTPγ[35S]. After 120 min at room temperature, the plates are centrifuged for 10 min at 300 × g and counted.
体外活性	在小鼠体内BAF312的预防或治疗剂量为0.3 mg/kg.在大鼠中,BAF312通过内化S1P1受体,从而有效抑制大鼠脑脊髓炎.
体内活性	BAF312 是有效的选择性S1P受体激动剂。它对S1P1和S1P5受体的EC50 分别为 0.39 nM 和 0.98 nM,并且对S1P1和S1P5受体的效力高于S1P2,S1P3 和 S1P4受体1000多倍。
存储条件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	Ethanol : 41 mg/mL (79.4 mM) DMSO : 5.17 mg/mL (10 mM)
关键字	inflammation \| Lysophospholipid Receptor \| S1P receptor \| inhibit \| neurodegeneration \| Siponimod \| S1P1 agonist \| progressive \| multiple sclerosis \| lymphocytes \| BAF312 \| LPL Receptor \| BAF 312 \| Inhibitor
相关产品	S1PR1 modulator 1 \| Ozanimod \| LX-2931 \| Ceranib-2 \| SLP9101555 \| Ki16198 \| MP-A08 \| Fingolimod hydrochloride \| Fingolimod \| CYM50374 \| CYM50260 \| ASP-4058
相关库	经典已知活性库 \| 抗癌上市药物库 \| 已知活性化合物库 \| EMA 上市药物库 \| 高选择性抑制剂库 \| GPCR靶点分子库 \| 膜蛋白靶向化合物库 \| 神经退行性疾病化合物库 \| 药物功能重定位化合物库 \| 抗癌药物库

辛波莫德|||BAF-312|TargetMol

上海陶术生物科技有限公司为美国Target Molecule Corp. ( Target Mol ) 在上海建立的全资子公司。我们与美国波士顿、德国慕尼黑的同事一起，为北美、欧洲和亚洲从事药物研发和生物学研究的科学家提供优质的产品和专业的服务。公司下设筛选事业部，化学事业部，生物事业部和新材料部。从虚拟筛选到实体化合物分子供应；从商业化产品销售到个性化定制合成；从对明确靶点的分子筛选到对明确分子的多靶点筛选，从高通量筛选到化学结构优化，我们都可以满足您的科研用品及技术服务的需求。经过在中国市场五年的精心耕耘，我们已成为筛选化合物领域优秀的供应商，为超过五百家学校和各类企业提供了品质卓越的小分子化合物和药物筛

成立日期	(12年)
注册资本	566.2651万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,试剂,定制,服务
主营行业	化学试剂,生物活性小分子